JAK3 and glioblastoma: Interestingly, both WHI-P131 and PF-956980 treatment of U87 and U251 cells showed increased expression of DNMT1 (Figure 5a,b) compared with untreated cells, suggesting that the JAK3 inhibitors are able to alter the epigenetic state of GBM cells.